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The identiﬁcation of individuals carrying unexpressed ge-
netic liabilitytoschizophreniais crucialfor bothetiological
research andclinical risk stratiﬁcation.Subclinical psycho-
pathological features detectable in the nonpsychotic part of
the schizophrenia spectrum could improve the delineation
of informative vulnerability phenotypes. Inspired by
Meehl’s schizotaxia-schizotypy heuristic model, we tested
anomalous subjective experiences (self-disorders, SDs) as
a candidate vulnerability phenotype in a sample of nonpsy-
chotic, genetically high-risk subjects. A total of 218 unaf-
fected members of 6 extended multiplex families (assessed
between1989and1999duringtheCopenhagenSchizophre-
nia Linkage Study) were stratiﬁed into 4 groups of increas-
ing psychopathological expressivity: no mental illness
(NMI), no mental illness with schizotypal traits (NMI-
ST), personality disorders not fulﬁlling other personality
disorders (OPDs), and schizotypal personality disorder
(SPD). We tested the distribution of SDs among the sub-
groups, the effect of SDs on the risk of belonging to the
different subgroups, and the effect of experimental group-
ing and concomitant psychopathology (ie, negative symp-
toms (NSs) and subpsychotic formal thought disorder
[FTD]) on the chances of experiencing SDs. SDs distribu-
tion followed an incremental pattern from NMI to SPD.
SDs were associated with a markedly increased risk of
NMI-ST, OPDs, or SPD. The odds of SDs increased as
a function of the diagnostic category assignment, indepen-
dently of sociodemographics and concomitant subclinical
psychopathology (NSs and FTD). The results support
SDs as an expression of schizotaxic vulnerability and indi-
cate a multidimensional model of schizotypy—character-
ized by SDs, NSs, FTD—as a promising heuristic
construct to address liability phenotypes in genetically
high-risk studies.
Key words: schizophrenia spectrum/schizotaxia/
schizotypal personality disorder/anomalous self-
experience/vulnerability phenotype/genetic high risk
Introduction
Throughout much of the last century, the search for etio-
logically informative phenotypes and the study of the
genetic architecture of the ‘‘schizophrenia-spectrum
(SzSp)disorders’’generatedabewilderingarrayofdata.
1–3
Several approaches were launched: clinical-
psychopathological studies (studying clinically expressed
conditions, such as schizophrenia, Diagnostic and Statis-
tical Manual of Mental Disorders odd-eccentric cluster
personality disorders, and—recently—prodromal/ultra-
high risk conditions, as the unit of analysis), genetic
high-risk studies (addressing population at enhanced
genetic susceptibility, mainly children of schizophrenia
probands), genetic-epidemiological surveys (eg, Roscom-
mon
4), and the psychometric high-risk research (studying
persons exceeding thresholds of assumed psychometric
measures of schizotypy/schizophrenia proneness).
5
Yet, despite all these efforts, the limits of SzSp itself re-
mainunclear.Asdemonstratedbythepolydiagnosticstud-
ies, even the prototype, the extreme and exemplary SzSp
condition—namely schizophrenia—has variable borders,
changing with the diagnostic system of reference.
6,7
Furthermore, there is still a lack of agreement on the
core features of SzSp, evoking relevant questions for
bothresearchandclinicalpractice.Hence,the‘‘qualitative
similarities’’thatinspiredverynotionoftheSzSpofdisor-
ders of Kety et al
8 remain somehow elusive and fairly un-
addressed by contemporary research. This is particularly
surprising because the idea of a gradient of psychopatho-
logical expressivity has been almost inseparable from the
very concept of schizophrenia since its emergence.
5
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1017The Continuum Beyond the Spectrum: From Kraepelin
to Meehl
Seminal observations by Kraepelin and Bleuler revealed
thatbiologicalrelativesofschizophreniapatientsoftendis-
playedsubtleformalthoughtdisorder(FTD)andinterper-
sonal oddities.
9–11 Later (elaborating upon Rado’s
12
originalhypothesis),Meehlproposedthetermschizotaxia
for the ‘‘genetically determined integrative defect, predis-
posingtoschizophrenia’’andthetermschizotypyforasub-
tly deviant psychobehavioral organization, reflective of
interactions of the schizotaxic vulnerability with environ-
mental factors.
13,14 An alternative, different but related,
approachreconceptualizesschizotaxiaasadiscretepheno-
typic class characterized by slight cognitive disturbances
and negative symptoms (NSs),
11,15,16 assumed to occur
in20%–50%offirst-degreerelativesofpatientswithschizo-
phrenia.
15,16Nevertheless,Meehl’sschizotaxia-schizotypy
paradigm remains at the heuristic core of contemporary
etiologicmodelsofSzSpdisorders.
17Itassumesthatschiz-
otaxicindividuals,whocarryanunderlyinggeneticvulner-
ability, will manifest schizotypy on a dynamic continuum
ofincreasingseveritydependingonthehistoryofdevelop-
mentalinteractionbetweengenesandbiopsychosocialrisk
factors. Such continuum ranges from relative psychologi-
calhealthtovariousdegreesofsubclinicaldeviancetoSzSp
personality disorders to full-blown schizophrenia.
13,14
Thus, it accommodates genetic and environmental contri-
butionstoliabilitywithinadevelopmentalframe,account-
ing for a range of clinical and subclinical outcomes.
Self-disorders and the Schizophrenia Spectrum
Recentyearshavewitnessedarebirthofinterestinthedo-
main of subjectivity and its disturbances, particularly
anomalous subjective experience of nonpsychotic inten-
sity and quality.
18,19 This interest is amplified by the on-
going, widespread research on the preonset stages of
schizophrenia and other psychotic disorders.
20–22 Curi-
ously, such subtle (nonpsychotic) qualitative changes of
subjective experience were described in the early 20th
centuryandwerethoughttobeintrinsictoschizophrenia,
coconstituting the specificity of its characteristic gestalt.
However, they were ignored by the contemporary psychi-
atry, mainly due to the dominating behavioristic
approach.
23,24
Both qualitative
24–26 and empirical
20,22,27,28 research
consistently indicate that certain anomalous subjective
experiences antedate the onset of psychosis. Clinically,
anomalous subjective experiences
24 encompass a broad
range of phenomena—from affect, perception, and expe-
rience of cognition and action to bodily experiences more
generally—all of which fall below the threshold of psy-
choticsymptoms(ie,delusionsandhallucinations).Forin-
stance, they include various disturbances in the stream of
consciousness (eg, thought interference), mild perceptual
aberrations, anomalous bodily experiences (eg, somatic
depersonalization), lack of a sense of immersion in the
world (eg, anhedonia, diminished vitality), and various
other disorders of self-consciousness. (Extensive catalogs
of these anomalous subjective experiences are available in
the form of systematic checklists: the Bonn Scale for the
Assessment ofBasicSymptoms[BSABS]; the Schizophre-
nia Proneness Instrument-Adult [SPI-A] version; and the
ExaminationofAnomalousSelf-experience[EASE]).
29–31
For detailed phenomenological descriptions and theoret-
ical considerations on anomalous subjective experience,
see Parnas and Handest
24 and Sass and Parnas.
19
Inrecentyears,ourownpsychopathologicalresearchon
essential features of schizophrenia (in continuity with the
Copenhagen High-Risk and Linkage Study
32,33) explored
a subset of anomalous experience, namely, self-disorders
(SDs). SDs have been considered to be central features of
the psychopathology ofschizophreniasince the very foun-
dationoftheconcept(Bleuler,Kraepelin,Berze,andKron-
feld [see Parnas and Handest
24]). They comprise unstable
or attenuated sense of self-presence, lack of basic sense of
self-coincidence (identity), blurred self-demarcation, dis-
turbanceinthetacitfluidityofthefieldofawareness,hyper-
reflexivity, and difficulty in grasping familiar meanings.
19
Our studies suggest that SDs form an important phe-
notype for the characterization of SzSp disorders, both in
clinical and in genetically high-risk populations. In
a study following the pilot data,
34 we found that SDs dis-
criminate International Classification of Diseases, Tenth
Revision (ICD-10), schizophrenia in remission (elevated
levels) from psychotic bipolar illness in remission. In
a prospective longitudinal study of 155 first-admission
cases, we showed that SDs aggregated selectively among
the ICD-10 nonaffective psychotic patients (mainly
schizophrenia patients) and in patients with schizotypal
disorders but not in the diagnostic categories outside the
spectrum.
28,35Finally,inaninterdiagnosticstudyonage-
netically high-risk population, we found that SDs distri-
bution mirrors the pattern already demonstrated by the
clinical samples: SzSp conditions (ie, schizophrenia and
schizotypal personality disorder [SPD]) had higher SDs
levels than those of other (nonspectrum) diagnostic
groups or individuals with no psychiatric diagnosis.
36 In-
dependent studies of unaffected first-degree relatives of
schizophrenia probands indicated that the level of SDs
in such relatives is intermediate between normal control
subjects and clinically overt SzSp disorders
37,38 and cor-
relates with the severity of the schizotypal traits.
39
Hypothesis Generation and Rationale for Experimental
Design
Against this background, we designed the current study
to examine SDs as a potential phenotype to track schiz-
otaxic liability in genetically high-risk populations. We
used a multigenerational sample derived from 6 extended
family pedigrees, previously assessed in the Copenhagen
A. Raballo & J. Parnas
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32,40 In order to target the
continuum of liability below the threshold of psychosis,
we used a graded construct of schizotypy as a unit of
analysis. Operatively, we assumed that detectable schiz-
otypal traits, detectable personality disorder, and detect-
able SPD reflect increasing degrees of manifestation of
schizotypy (in the sense of a ‘‘latent personality organi-
zation’’inschizotaxicindividuals).
12,14Weoptedforsuch
heuristic stratification because it offers recognizable an-
chor points of increasing clinical severity that can be di-
rectly mapped on Diagnostic and Statistical Manual of
Mental Disorders (Third Edition Revised) (DSM-III-R)
criteria (eg, criteria for Axis II disorders and criteria
for SPD). Further, we hypothesized that anomalous sub-
jective experiences (SDs) can provide points of entry for
identifying schizotypic individuals at various thresholds
of subclinical expressivity.
We therefore tested the following:
1. the distribution of SDs among the subgroups (assum-
ing that it would show a gradient-like pattern);
2. theeffectofSDsinmoderatingtheriskofbelongingto
the nonpsychotic part of the SzSp (expecting SDs to
increasetheriskofbelongingtothegroupswithhigher
degrees of schizotypy);
3. the effect of diagnostic assignment and concomitant
(subclinical) psychopathology on the chances of expe-
riencingSDs(expectingtheassignmenttobethestron-
gest predictor of SDs odds).
InadditiontoSDs,inordertomapsalientpsychopath-
ological dimensions in nonpsychotic genetically high-risk
subjects, we used assessments of NSs and FTD. Indeed,
both original descriptions from Kraepelin and Bleuler
and studies of relatives of schizophrenic patients
41–44 in-
dicate that the negative and disorganized dimension of
schizophrenia may be a part of the constellation of fea-
tures that mark genetic vulnerability for the disorder.
Methods
Sample
The sample included 218 nonpsychotic members of 6 ex-
tended multiplex families, previously assessed in the
Copenhagen Schizophrenia Linkage Study. The Copen-
hagen Schizophrenia Linkage Study began in 1989 and
was directly inspired by the findings from high-risk stud-
ies (such as the Copenhagen High-Risk Study
33 and the
Danish Adoption Study
8) that confirmed the existence of
a SzSp disorder, described as nonpsychotic pathological
conditions significantly aggregating among biological
relatives of schizophrenic individuals.
45 Experimentally
and logistically, the Copenhagen Schizophrenia Linkage
Study was an outgrowth of the Copenhagen High-Risk
Study
33 and was guided by a hypothesis that extended
pedigree information—comprising phenotypes such as
schizotypal disorder and markers such as thought disor-
der index
40 and eye tracking dysfunction
32—might sub-
stantially contribute to mapping the alleles implicated
in schizophrenia.
TheCopenhagenSchizophreniaLinkageStudytargeted
6families(whosegenogramsarereportedinVaeveretal
40),
identified through the following procedure. Originally, 6
individuals with a diagnosis of schizophrenia were identi-
fiedintheCopenhagenHigh-RiskStudy,whosepedigrees
werefoundtohavethefollowingcharacteristics:(1)many
livingmembers(minimumage15y,nomaximumage),(2)
at least 2 first-degree family members with a reliable diag-
nosis of schizophrenia (based on clinical documentation
and mental health registry), and (3) reports from family
members and from psychiatric case register of distant rel-
atives with any psychiatric problem. Each pedigree was
centeredon1ofthe6originalschizophrenicprobands’nu-
clear families; this proband was used as the starting point
for extending the family trees both horizontally (eg, sib-
lings, cousins) and vertically (eg, parents, grandparents,
offspring).Itshouldbenotedthattheinvestigatorsfavored
pedigrees that could be extended (ie, families with many
siblings,aunts,cousins,etc),whichrepresentedupto6gen-
erations,includingthenuclearfamilies(eg,therewasafam-
ily with 12 offspring, and one pedigree consisted of 175
living members).
Pedigreeinformationwascollectedon618subjects(see
Matthysse et al
32 and Vaever et al
40) of which 347 were
personally interviewed and assessed on multiple domains
(sociodemographic, psychopathological, neuropsycho-
logical).
32,36,40
Two senior clinicians administered the Copenhagen In-
terview of Functional Illness
46 to all the enrolled partici-
pants, blind to any diagnostic information, clues to the
kinshipstatus,andsurnamesofthesubjects.Theinterview
contained the psychosis section from the Present State
Examination
47; an abbreviated Personality Disorder Ex-
amination(PDE)
48;theThought,Language,andCommu-
nication(TLC)
49Scale;ScalefortheAssessmentofPositive
SymptomsandScalefortheAssessmentofNegativeSymp-
toms (SANS)
50,51; Schedule for Affective Disorder and
Schizophrenia—Lifetime Version (items concerning all
nonpsychotic disorders)
52; a list of anomalous subjective
experiencesmostlyderivedfromthesectionsC(ie,cognitive
thought,perception,andmotordisturbances)andD(ie,im-
paired bodily sensations) of a preliminary version of the
BSABS
29; and singleinterview items used in the Copenha-
gen Adoption
8 and High-Risk
33 studies.
Complete psychopathological data on SDs were avail-
ablein305participants.
36Fromthissubgroup,weextracted
the final experimental sample on the basis of a heuristic
operationalization of Meehl schizotaxia-schizotypy con-
struct. We excluded those with any comorbid (DSM-III-
R)AxisIcondition(n=29schizophreniaorotherpsychoses,
n = 22 affective disorders, n = 18 alcohol/substance-related
disorders, n = 10 other Axis I disorders). This restriction
1019
Schizotypy and the Schizotaxic Selfwas motivated by our intention to address subclinical fea-
tures of vulnerability to SzSp disorders, and thus, besides
excluding schizophrenia, we wanted to avoid confounders
duetoothermajorAxisIclinicaldisorders(eg,affectivedis-
orders,alcohol,ordrugabuse).Finally,wedidnotinclude
thefew(n=8)schizoidsandparanoids(toofewtobeaclass
for itself) because the meaningof these terms in their post-
MeehlDSM-III-Rdefinitionhasbeentransformedintosus-
piciousness oregosyntonic introversion,with adubious or
no familial affinity to schizophrenia (see Parnas et al
5 for
a very extensive review of the matter).
Thefinal experimental samplewas therefore composed
of 218 subjects with a clinical expressivity ranging from
no mental illness topersonality disorders(ie, DSM-III-R,
Axis II conditions).
DuringtheCopenhagenSchizophreniaLinkageStudy,
DSM-III-R ‘‘lifetime’’ psychiatric diagnoses of each par-
ticipant were determined by consensus among 4 research
psychiatrists/psychologists using all available data sour-
ces. Interrater diagnostic reliability was assessed and pre-
vented from drift via regular group interview sessions
(interviews conducted by J.P.). The mean interrater reli-
ability ranged between 0.900 and 0.956, similar to that
reported in Parnas et al.
33
Study Variables
PhenotypicManifestnessofSchizotaxia:CategoricalDivi-
sionsofSchizotypyandSampleStratiﬁcation. Inorder to
captureinareproducibleway,thesubtlemanifestationsof
schizotaxic diathesis within a genetically high-risk, mainly
nonsymptomatic(ie,belowtheclinicalcasenesslevel)pop-
ulation, we operationalized the continuum of schizotypy
according to the available clinical diagnostic information.
This subdivision was motivated by a rational-pragmatic
approach to Meehl’s schizotaxia-schizotypy model and
basedonclinicallyrecognizablethresholds.Weconsidered
subjects with no signs of mental illness and no schizotypal
traits as a reference category. A second threshold was the
presence of some schizotypal traits in the context of an
otherwise nonpathological personality organization (ie,
not fulfilling the criteria for any DSM-III-R personality
disorders).Athirdthresholdwasthepresenceofa‘‘perva-
sive pattern’’ of behavior and experiences configuring
a personality disorder. The final threshold was the pres-
ence of the specific ‘‘pervasive pattern’’ of behavior and
experiences indicative of SPD. We assumed that those
thresholds could approximate distinguishable escalating
manifestations of schizotypy in Meehl’s sense.
14
Hence, we stratified the sample as follows:
1. No personality deviations and no schizotypal traits;
the corresponding sample, termed no mental illness
(NMI), included 79 participants.
2. Few schizotypal traits but no personality deviations;
the corresponding sample, termed no mental illness
with schizotypal traits (NMI-ST), included 24 partic-
ipants. Operatively, in order to set a clinically tangible
threshold, the subjects included in the group needed to
fulfill at least 2 of the DSM-III-R criteria for SPD;
subjects fulfilling only one of the SPD criteria were in-
cluded in NMI (group 1).
3. Personality deviations, reaching the threshold for
a DSM-III-R personality disorder but not fulfilling
the criteria for full-fledged SPD. The corresponding
sample, termed other personality disorders (OPDs),
included 62 participants, 56 of whom also had comor-
bid schizotypal traits.
4. SPD, subjects reaching the threshold for the relevant
DSM-III-R diagnosis and with no comorbid Axis I
psychotic conditions. The SPD sample included 53
participants.
Psychopathological Dimensions: SDs, NSs, and FTD A
broad range of anomalous subjective experience was ex-
plored through the Copenhagen Interview of Functional
Illness,
46 which contains items derived from the BSABS
29
and the PDE.
48
The items derived from the BSABS were originally
adapted to the specific study population of the Copenha-
gen Schizophrenia Linkage Study (ie, non–help-seeking
genetically high-risk subjects) in order to assess the
lifetime prevalence of subtle enduring distortions of
subjective experience, conceived as trait features. The
original coding of these items was 0 (not present), 1
(doubtfully present), or 2 (definitely present). However,
because only few participants received score 1, this score
was recoded into 0 (not present) and 2 redefined as 1
(present).
The SDs score used for the current data analysis was
based on a rational selection of items considered perti-
nent tothe construct. That scaleyielded excellent internal
coherence (Cronbach a = .81) in the same genetically
high-risk population.
36 Further details on the SDs score
generation and item composition are available open ac-
cess
36 and recapitulated in the Appendix.
Briefly,theSDsscoreforeachsubjectwascalculatedas
a sum of ratings of the individual scale items (which had
values 0 or 1). Clinically, the SDs score addresses a com-
prehensive set of self-experience, ranging from subtle de-
personalization, perplexity, sense of anonymity, and
interference of thoughts to more thematic or explicit
levels of identity disturbance. See the Appendix for the
specific item composition.
NSsandFTDwereassessedwiththeSANS
51andTLC
Scale.
49 Dimensional scores were computed for the pur-
pose of data analysis.
Statistical Analysis
We explored the sociodemographic and psychopatholog-
ical features of the samples using v
2 test for categorical
variables and Welch weighted analysis of variance for
continuous variables. We then used multinomial logistic
1020
A. Raballo & J. Parnasregression to estimate the risk of belonging to the exper-
imental categories (ie, NMI-ST, OPDs, and SPD, with
NMI as reference class) as a function of SDs, contextu-
allycontrollingforsociodemographicandotherpsycho-
pathological variables. We chose multinomial logistic
regression, rather than ordinal logistic regression, be-
cause the proportional odds assumption could not be
made, ie, we could not assume that the postulated
SDs effect on the dependent variable (experimental
grouping) is the same across the different categories
(ie, NMI, NMI-ST, OPDs, SPD), given the diagnostic
heterogeneity of the subjects.
In a second step—with the binary logistic regres-
sion—we estimated the effect of schizotypal class allo-
cation on the risk of experiencing SDs, adjusting for
sociodemographics and concomitant psychopathology
as covariates.
Results
Descriptive,sociodemographic,andpsychopathological
features of the sample are presented in table 1. The ex-
perimental subgroups differ with respect to age—which
is higher in NMI—and psychopathological dimensions;
post hoc analysis confirms the expected increase in SDs,
NSs, and FTD from NMI to SPD (specific patterns are
detailed in table 1).
The multinomial logistic regression analysis (table 2)
shows that SDs are significantly associated with all the
experimental schizotypy groups compared with the
base category, NMI. The relative risk ratio increases
from NMI-ST to OPDs to SPD. Similarly, NSs and
FTD model the schizotypal class allocation. Specifically,
SDs and NSs contribute to predict NMI-ST, OPDs, and
SPD. FTD contributes to OPDs and SPD. Among the
sociodemographicvariables,ageshowsasignificantasso-
ciation with OPDs; however, the effect size is clinically
marginal (ie, the chance of belonging to OPDs vs NMI
groupdecreases of3% for each year of difference in age).
The overall model explained a substantial part of the
variance (Nagelkerke pseudo-R
2 = 0.58).
Table 3 presents the results of binary logistic regres-
sion: all the schizotypy classes have a significant effect
on the odds of experiencing SDs. The effect of age is sta-
tistically significant yet, as in the previous analysis, of
modest size (ie, 2–3 orders of magnitude below NMI-
ST, OPDs, SPD). Gender and contextual psychopathol-
ogy (ie, NSs and FTD) do not influence SDs odds. The
overall model explained almost 40% of the variance
(Nagelkerke R
2 = 0.397).
Discussion
In this study, we examined the hypothesis that SDs are a
core phenotypicmanifestationofthat ‘‘latentpersonality
organization’’ (ie, schizotypy) that Meehl postulated as
‘‘a necessary but variable phenotypic embodiment of
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Schizotypy and the Schizotaxic Selfschizotaxicvulnerability.’’Specifically,ourpurposewasto
testthecapacityofSDstodetectsubclinicalconfigurations
ofschizotypy(gradedasNMI,NMI-ST,OPDs,andSPD)
in the nonpsychotic part of the SzSp.
Overall, the results are consistent with our research hy-
pothesis. SDs are associated with increasing schizotypal
phenotypic expressivity in nonpsychotic genetically high-
risk populations. They display an increasing quantitative
pattern from NMI to SPD, and the level of SDs increases
the relative risk of displaying psychopathological features
ofschizotypy.SuchpatternismirroredbyNSsand,partly,
by FTD (which increases the odds of belonging to OPDs
and SPD group), 2 symptom dimensions consistently
reported as indicative of the constellation of traits that
mark genetic vulnerability for schizophrenia.
41–44 Also,
as shown by the binary logistic regression, the odds of
experiencing SDs are primarily associated with the degree
of schizotypal expressivity, independent of concomitant
psychopathology (ie, NSs and FTD).
The study corroborates the concept of SDs as a valu-
able, quantitatively tractable, trait phenotype for index-
ing genetic liability to SzSp. Indeed, although in
previous studies we demonstrated that SDs are a distin-
guishing psychopathological feature of the SzSp disor-
ders both in clinical
28,34 and in genetically high-risk
populations,
36 this is the first study that shows their
classificatory power with respect to subclinical configu-
rations of the SzSp. Concretely, the ‘‘resolution power’’
of SDs as a liability marker extends beyond the clinical
side of SzSp (ie, diagnosable SPD and Schizophrenia) to
reach subthreshold manifestations in subjects with no
personality disorder but detectable schizotypal traits.
This has certain (nontrivial) conceptual, empirical, and
clinical implications. Briefly:
1. With respect to genetic research, it provides a possible
delineation of specific quantitative traits—indicative
of clinically unexpressed SzSp vulnerability—that
Table 2. Multinomial Logistic Regression Analysis: Schizotypal Class Allocation as Outcome Variable
NMI-ST Vs NMI OPD Vs NMI SDP Vs NMI
Estimated
Relative
Risk Ratio
95% Conﬁdence
Intervals
Estimated
Relative
Risk Ratio
95% Conﬁdence
Intervals
Estimated
Relative
Risk Ratio
95% Conﬁdence
Intervals
Sociodemographic
Gender
a 1.080 0.409–2.849 0.535 0.225–1.273 0.686 0.244–1.928
Age (y) 0.975 0.946–1.005 0.972* 0.946–0.998 0.986 0.955–1.019
Psychopathological
Self-disorders 1.646* 1.063–2.549 1.944** 1.294–2.920 2.309*** 1.528–3.489
Negative symptoms 1.207* 1.021–1.428 1.324*** 1.142–1.535 1.458*** 1.250–1.702
Formal thought disorder 1.056 0.862–1.292 1.300** 1.119–1.510 1.326** 1.131–1.554
Note: NMI-ST, no mental illness with schizotypal traits; NMI, no mental illness; OPDs, other personality disorders; SPD, schizotypal
personality disorder. Model fit: v
2 = 167.27, df = 15, P < .0001.
aMale as reference category for gender.
*P < .05; **P < .01; ***P < .001.
Table 3. Binary Logistic Regression: Presence/Absence of Self-disorders as Outcome Variable
Adjusted Odds Ratio 95% Conﬁdence Intervals P Value Wald Statistic
Sociodemographic
Gender
a 0.84 0.43–1.61 .5915 0.29
Age (y) 0.97 0.95–1.00 .0171 5.69
Schizotypal class
b
NMI-ST 3.76 1.27–11.16 .0169 5.71
OPD 5.24 2.05–13.39 .0005 11.98
SPD 25.06 7.86–79.88 <.0001 29.67
Psychopathological
Negative symptoms 0.94 0.88–1.01 .1016 2.68
Formal thought disorder 1.08 1.00–1.17 .0585 3.58
Note: NMI-ST, no mental illness with schizotypal traits; OPDs, other personality disorders; SPD, schizotypal personality disorder.
Model fit: v
2 = 76.03, df = 7, P < .0001.
aMale as reference category.
bNMI as reference category.
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A. Raballo & J. Parnascan empower linkage and association studies and help
illuminate the genetic architecture of the underlying
schizotaxic diathesis.
15,53
2. FromtheviewpointoftheconstructvalidityofSzSp,it
provides a core feature that could serve as a prototyp-
ical trait on a continuum of expressivity ranging from
subtle personality deviations to full-fledged clinical
configurations.
3. With respectto early recognition researchintervention
programs, it can help supplement current criteria to
identify people at risk of psychosis, enriching current
prodromal and ultrahigh risk models (which mostly
rely on state-like symptoms
21,22), with a candidate
quantitative trait phenotype associated with schizo-
taxic risk.
4. Similarly, from the viewpoint of translational impact
on clinical practice, it provides the rationale for the in-
clusion of SDs in clinical assessment practices. SDs
(eventually explored with newly available interview
checklists, such as SPI-A
31 and EASE
30) can help
form differential diagnoses indicating subjects with
SzSp vulnerability and hence support more compre-
hensive clinical decision making, particularly in situa-
tionswherediagnosticallocationisnotimmediate.
54,55
Finally, the observed relationships between SDs, NSs,
FTD,anddifferentclassesofschizotypalexpressivitywar-
rantsacomment.Thesignificancelevelsobtainedforeach
of the 3 models in the multinomial logistic regression
(table1)indicatethattheindependentpsychopathological
variables (SDs, NSs, FTD) significantly contribute to dis-
criminate NMI-ST, OPDs, SPD from the reference class
(NMI). This coheres with a multidimensional construct
of schizotypy and confirms that NSs and FTD constitute
subclinical featuresof schizotaxic vulnerability.
56,57Thus,
acompositephenotype(dimensionallymappingSDs,NSs,
FTD) may be even more useful.
Limitations
Theseresultsshouldbeinterpretedinthecontextof6main
methodological limitations. First, our stratification of
schizotypy in 4 classes is a rough approximation of clini-
cally plausible thresholds, mostly performed for the pur-
pose of hypothesis testing. Therefore, a more refined
heuristic stratification of Meehl’s schizotypy continuum
model is warranted. Also, the sample characterization in
terms of diagnostic assessment was based on DSM-III-R
operational criteria, which are not optimal to capture all
possibly relevant signs and symptoms of schizotypy. Sec-
ond, all participants were members of multiplex families;
hence, the reference category we used for the analysis,
NMI (ie, subjects with no personality deviations and no
schizotypaltraits),stillbelongsbydefinitiontoagenetically
high-risk population and cannot be equated to a commu-
nity sample. However, this feature should reduce, rather
than amplify, the quantitative differences in SDs across
the experimental subgroups. Third, the assessment of
SDswasperformedbymeansofapsychometricproxy:adi-
mensional score obtained aggregating available psycho-
pathological items (Appendix) assessed on the basis of
their lifetime prevalence as trait features (see ‘‘Methods’’
section).Thisoffersonlyanapproximationofthepotential
range of manifestations of SDs and does not allow more
detailed analysis (eg, explore features like intrusiveness,
pervasiveness, and temporal coaggregation) that would
have required more sophisticated instruments (eg,
EASE
30).
Fourth, given the circumscribed experimental aim of
the current study (ie, to test if SDs detect subclinical con-
figurations of schizotypy in unaffected genetically high-
risk subjects), we did not perform any further analysis to
address the individual genetic risk of the participants. In-
deed, given the complexity of the pedigrees, this could
have not been done by the simple stratification (first de-
gree,seconddegree,etc)butwouldrequireacomputation
of each family member’s true genetic vulnerability (ie,
taking into account his unique position in the genogram
and hence all his affected relatives, close and distant
36).
Fifth, our use of only 2 domains of concomitant subclin-
ical psychopathology, ie, NSs and FTD, may be an over-
simplification of the multifaceted variability of SzSp
psychopathology in unaffected family members, but
there is no consensus in the field about the number of
dimensions that best represents the full clinical picture
of SzSp diathesis. Hence, to qualify schizotaxia, we opted
to use NSs and FTD because of their historical promi-
nence and the consistent empirical evidence in the liter-
ature.
41–44 Finally, it ought to be pointed out that the
study is based on a population sample, which is mainly
nonclinicalandonlydiagnosedinthecontextsofagenetic
research protocol. Thus, the diagnoses are not dependent
on contact with treatment facilities, and the clinical
expressivity—even in the case of OPDs and SPD—is
plausibly less flamboyant than in patient population.
This not only reduces the generalizability of the results
outside genetically high-risk samples but also minimizes
the phenotypic background noise due to the confounding
effect of hospitalization, psychotropic medications, mar-
ginalized social status, and cognitive and personality de-
terioration.
Conclusion
Despite the profusion of candidate phenotypic taxono-
mies, the delineation of informative SzSp vulnerability
phenotypesisstillavexingissueincontemporaryresearch.
This study, informed by Meehl’s schizotaxia-schizotypy
model, tested the validity of anomalous self-experiences
(SDs) as a candidate vulnerability phenotype in a sample
of nonpsychotic, genetically high-risk subjects.
Our results confirmed the experimental hypothesis,
showing that SDs’ classificatory power—previously
1023
Schizotypy and the Schizotaxic Selfdemonstrated for clinical conditions
28,34,36—also reaches
thoseinfraclinicalconditionsthatconstitutethesilentpart
of the SzSp. This discriminatory power is comparable to
that of alleged markers of schizotaxic diathesis, such as
subclinicalNSsandFTD,andindependentfromconcom-
itantpsychopathology.Thiscapacitytodetectsubclinical
manifestations of schizotypy suggests that SDs form
a promising candidate for tracking disease susceptibility
in asymptomatic (ie, nonclinical) genetic carriers.
Future research should test:
1. ifSDs, besidescovaryingwith the likelihoodofexpres-
sion of schizotypical configurations, are also propor-
tional to the degree of genetic relatedness (taking into
consideration the complex architecture of pedigrees)
and follow the same transgenerational pattern of
transmission;
2. the longitudinal stability and predictive value of SDs
with respect to the lifetime development and expres-
sion of schizotypy.
Finally, the results indicate a multidimensional model
of schizotypal vulnerability (including SDs, NSs, and
FTDascompositedescriptors)asanempiricallygrounded
prototype to address the heritable SzSp predisposition.
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Appendix. Self-Disorder Scale, Item Composition
36
Copenhagen Interview
of Functional Illness
(Section and Item
Code)
46 Content
Personality
exploration—11
Gender identity
problems/anxiety of
being homosexual (refers
not to homosexuality
but to pervasive lack of
identity)
Personality
exploration—12a
Identity disturbance,
does not know who he/
she is (like a sense of
being extraterrestrial)
Appendix Table. Continued
Copenhagen Interview
of Functional Illness
(Section and Item
Code)
46 Content
Personality
exploration—12b
Often feels self is
different at different
times (as numerically
different)
Personality
exploration—12c
Frequent shifts in
opinion about how he/
she should live life (loss
of natural engagement,
hyperreﬂexivity)
Subjective
experience—25
Feels perplexed,
confused, or has lost
feelings of the world’s
naturalness or meaning
Subjective
experience—28
Has lost leniency and
needs to reﬂect on the
simplest things
(hyperreﬂexivity)
Subjective
experience—47
Feels he/she has no
feelings for him/herself
and/or the world
Subjective
experience—48
Feels that he/she is not
really alive
Subjective
experience—51
Thought block
Subjective
experience—52
Thought emptiness
Subjective
experience—54
Feels that he/she is
disappearing
Subjective
experience—55
Feels that there are no
boundaries between him/
herself and the
surroundings
Subjective
experience—71
Feels he/she has lost all
feelings of pleasure
(anhedonia)
Subjective
experience—87
Feels like a stranger to
him/herself
Subjective
experience—74
Loss of thought control
Subjective
experience—75
Thought pressure
Subjective
experience—76
Thoughts are felt strange
and anonymous
Subjective
experience—82
Thought can be
apprehended by others
Subjective
experience—89
Feels that his/her
appearance changes
when he/she looks in the
mirror
Subjective
experience—98
Feels it is necessary to
concentrate on body
movements that
normally are completed
automatically and
without reﬂection
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